Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure Peptides After Peptide Sciences Renew Vitality Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences